Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03005002
Title Durvalumab and Tremelimumab in Treating Patients With Microsatellite Stable Metastatic Colorectal Cancer to the Liver
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors City of Hope Medical Center

colorectal cancer


Durvalumab + Tremelimumab

Age Groups: adult
Covered Countries USA

No variant requirements are available.